Genpact Valuation

G Stock  USD 46.49  0.33  0.70%   
At this time, the firm appears to be fairly valued. Genpact Limited retains a regular Real Value of $47.56 per share. The prevalent price of the firm is $46.49. Our model calculates the value of Genpact Limited from evaluating the firm fundamentals such as Return On Equity of 0.3, return on asset of 0.0846, and Current Valuation of 9.09 B as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Genpact's valuation include:
Price Book
3.4481
Enterprise Value
9.1 B
Enterprise Value Ebitda
10.9906
Price Sales
1.7702
Forward PE
18.315
Fairly Valued
Today
46.49
Please note that Genpact's price fluctuation is very steady at this time. Calculation of the real value of Genpact Limited is based on 3 months time horizon. Increasing Genpact's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Genpact stock is determined by what a typical buyer is willing to pay for full or partial control of Genpact Limited. Since Genpact is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Genpact Stock. However, Genpact's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  46.49 Real  47.56 Target  42.67 Hype  46.45 Naive  44.9
The real value of Genpact Stock, also known as its intrinsic value, is the underlying worth of Genpact Limited Company, which is reflected in its stock price. It is based on Genpact's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Genpact's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
47.56
Real Value
49.23
Upside
Estimating the potential upside or downside of Genpact Limited helps investors to forecast how Genpact stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Genpact more accurately as focusing exclusively on Genpact's fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
0.800.810.81
Details
Hype
Prediction
LowEstimatedHigh
44.7846.4548.12
Details
Potential
Annual Dividend
LowForecastedHigh
0.050.050.05
Details
12 Analysts
Consensus
LowTarget PriceHigh
38.8342.6747.36
Details
When choosing an evaluation method for Genpact Limited, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.

Genpact Cash

449.55 Million

Genpact Valuation Trend

Comparing Genpact's enterprise value against its market capitalization is a good way to estimate the value of Genpact Limited uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.

Genpact Revenue by Product

Genpact Total Value Analysis

Genpact Limited is currently forecasted to have enterprise value of 9.09 B with market capitalization of 8.26 B, debt of 1.5 B, and cash on hands of 646.76 M. Please note that enterprise value may be misleading and is a subject to accounting manipulations. We encourage investors to cautiously inspect all of the Genpact fundamentals before making security selection decision based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
9.09 B
8.26 B
1.5 B
646.76 M

Genpact Investor Information

About 99.0% of the company shares are owned by institutional investors. The book value of Genpact was currently reported as 13.58. The company has Price/Earnings To Growth (PEG) ratio of 1.7. Genpact Limited last dividend was issued on the 9th of December 2024. Based on the key indicators related to Genpact's liquidity, profitability, solvency, and operating efficiency, Genpact Limited is performing exceptionally good at this time. It has a great probability to report excellent financial results in December.
Current ValueLast YearChange From Last Year 10 Year Trend
Operating Profit Margin0.10.1409
Way Down
Slightly volatile
Total Cash From Operating Activities347.3 M490.8 M
Way Down
Slightly volatile
Operating Income662.4 M630.9 M
Sufficiently Up
Slightly volatile

Genpact Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Genpact has an asset utilization ratio of 93.16 percent. This implies that the Company is making $0.93 for each dollar of assets. An increasing asset utilization means that Genpact Limited is more efficient with each dollar of assets it utilizes for everyday operations.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

Genpact Ownership Allocation

The majority of Genpact Limited outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Genpact to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Genpact Limited. Please pay attention to any change in the institutional holdings of Genpact Limited as this could imply that something significant has changed or is about to change at the company. On September 18, 2024, Representative Michael McCaul of US Congress acquired under $15k worth of Genpact Limited's common stock.

Genpact Profitability Analysis

The company reported the annual revenue of 4.48 B. Net Income to common stockholders was 631.25 M with gross profit before all taxes, overhead, and interest of 1.54 B.

Genpact Past Distributions to stockholders

Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Genpact's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Genpact and how it compares across the competition.

About Genpact Valuation

The stock valuation mechanism determines Genpact's current worth on a weekly basis. Our valuation model uses a comparative analysis of Genpact. We calculate exposure to Genpact's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Genpact's related companies.
Last ReportedProjected for Next Year
Gross Profit1.6 B902.8 M
Pretax Profit Margin 0.13  0.13 
Operating Profit Margin 0.14  0.10 
Net Profit Margin 0.14  0.11 
Gross Profit Margin 0.35  0.42 
Genpact's stock price is the clearest measure of market expectations about its performance. Without stock valuation, investors cannot independently discern whether Genpact's value is low or high relative to the company's performance and growth projections. Determining the market value of Genpact can be done in different ways, such as multiplying its stock price by its outstanding shares.
A single share of Genpact represents a small ownership stake in the entity. As a stockholder of Genpact, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.

Genpact Dividends Analysis For Valuation

Please note that Genpact has scaled down on payment of dividends at this time. The Genpact's current Retained Earnings is estimated to increase to about 1.1 B, while Retained Earnings Total Equity is projected to decrease to roughly 565.7 M.
There are various types of dividends Genpact can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Genpact shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Genpact Limited directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Genpact pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Genpact by the value of the dividends paid out.

Genpact Growth Indicators

Investing in growth stocks can be very risky. If the company such as Genpact does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding185.1 M
Quarterly Earnings Growth Y O Y0.156
Forward Price Earnings18.315

Genpact Current Valuation Indicators

Valuation refers to the process of determining the present value of Genpact Limited and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Genpact we look at many different elements of the entity such as Genpact's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Genpact, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Genpact's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Genpact's worth.

Complementary Tools for Genpact Stock analysis

When running Genpact's price analysis, check to measure Genpact's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genpact is operating at the current time. Most of Genpact's value examination focuses on studying past and present price action to predict the probability of Genpact's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genpact's price. Additionally, you may evaluate how the addition of Genpact to your portfolios can decrease your overall portfolio volatility.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Equity Valuation
Check real value of public entities based on technical and fundamental data
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios